SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: C

Cytokinetics (CYTK) might move higher on growing optimism about its earnings prospects, which is ref

The mean of analysts' price targets for Cytokinetics (CYTK) points to a 30.5% upside in the stock. W

The insider liquidated 7,500 shares at a weighted average price of $82.02. The disposition represent

CYTK enters a new era after Myqorzos FDA approval, with early US uptake, European expansion and life

RBC Capital analyst Leonid Timashev maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and lo

IWN delivered a 37.4% one-year return but carries higher fees, while ISCV offers a 0.06% expense rat

Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in

Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

UBS analyst Ashwani Verma upgrades Cytokinetics (NASDAQ:CYTK) from Neutral to Buy and raises the

Entertainment leader Sphere stock continues to outperform in the current market environment, setting

Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending

Mizuho analyst Salim Syed maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and raises the p

SOUTH SAN FRANCISCO, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: C

CYTK has gained 18.4% YTD as Myqorzo's FDA approval, early launch momentum, and expanding market opp

Cytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Program to Provide Donations to Non-Profit Organizations Aligned with Corporate Values Deadline for

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock?

European Launch Follows Strong U.S. Start SOUTH SAN FRANCISCO, Calif., and ZUG, Switzerland, June 01

SOUTH SAN FRANCISCO, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CY

Cytokinetics, Incorporated (CYTK) Shareholder/Analyst Call Prepared Remarks Transcript

Cytokinetics NASDAQ: CYTK executives said the commercial launch of MYKORZO is tracking ahead of inte

SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CY

SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CY

Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidanc

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Stocks That Hit 52-Week Highs On Wednesday

Stocks That Hit 52-Week Highs On Tuesday